Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Aug-24 4:30 PM View:  | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 09-Aug-24 | Sale | 814,874 | $4.25 | $3,463,210.00 | (16%) 5.03M to 4.22M | |
| 25-Mar-24 7:09 PM View: | Behanna Heather Director | Design Therapeutics, Inc. (DSGN) | 25-Mar-24 | Private Purchase | 1,300 | $3.74 | $4,865.77 | 100% 0 to 1.3K | |
| 25-Mar-24 7:10 PM View: | Schmid John P. Director | Design Therapeutics, Inc. (DSGN) | 25-Mar-24 | Purchase | 17,809 | $3.74 | $66,605.70 | 36% 48.99K to 66.8K | |
| 25-Mar-24 7:10 PM View: | Schmid John P. Director | Design Therapeutics, Inc. (DSGN) | 22-Mar-24 | Private Purchase | 9,156 | $3.62 | $33,132.80 | 23% 39.83K to 48.99K | |
| 02-Oct-23 10:00 PM View: | Lappe Rodney W Director | Design Therapeutics, Inc. (DSGN) | 29-Sep-23 | Private Purchase | 21,000 | $2.35 | $49,287.00 | 19% 112.02K to 133.02K | |
| 30-Aug-23 6:02 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 29-Aug-23 | Purchase | 1,960,000 | $2.44 | $4,782,400.00 | 64% 3.07M to 5.03M | |
| 30-Aug-23 6:06 PM View: | Prasad Deepa Director | Design Therapeutics, Inc. (DSGN) | 29-Aug-23 | Private Purchase | 12,000 | $2.31 | $27,669.60 | 102% 11.81K to 23.81K | |
| 30-Aug-23 6:02 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 28-Aug-23 | Private Purchase | 275,000 | $2.15 | $591,250.00 | 10% 2.8M to 3.07M | |
| 20-Dec-22 6:45 PM View: | George Simeon Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 20-Dec-22 | Purchase Duplicate | 40,000 | $8.14 | $325,432.00 | < 1% 6.49M to 6.53M | |
| 21-Dec-22 5:00 PM View: | Siffert Joao Md President and CEO Director | Design Therapeutics, Inc. (DSGN) | 20-Dec-22 | Purchase | 6,300 | $8.38 | $52,762.50 | 5% 126.32K to 132.62K | |
| 20-Dec-22 6:37 PM View: | Sr One Capital Fund I Aggre... 10% Owner | Design Therapeutics, Inc. (DSGN) | 20-Dec-22 | Purchase | 40,000 | $8.14 | $325,432.00 | < 1% 6.49M to 6.53M | |
| 20-Dec-22 6:45 PM View: | George Simeon Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 19-Dec-22 | Purchase Duplicate | 360,000 | $8.63 | $3,108,100.00 | 6% 6.13M to 6.49M | |
| 21-Dec-22 5:00 PM View: | Siffert Joao Md President and CEO Director | Design Therapeutics, Inc. (DSGN) | 19-Dec-22 | Private Purchase | 1,150 | $8.47 | $9,740.50 | < 1% 125.17K to 126.32K | |
| 20-Dec-22 6:37 PM View: | Sr One Capital Fund I Aggre... 10% Owner | Design Therapeutics, Inc. (DSGN) | 19-Dec-22 | Purchase | 360,000 | $8.63 | $3,108,100.00 | 6% 6.13M to 6.49M | |
| 20-Dec-22 6:37 PM View: | Sr One Capital Fund I Aggre... 10% Owner | Design Therapeutics, Inc. (DSGN) | 16-Dec-22 | Private Purchase | 500,000 | $8.28 | $4,140,550.00 | 9% 5.63M to 6.13M | |
| 20-Dec-22 6:45 PM View: | George Simeon Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 16-Dec-22 | Private Purchase Duplicate | 500,000 | $8.28 | $4,140,550.00 | 9% 5.63M to 6.13M | |
| 12-Dec-22 5:22 PM View: | Lappe Rodney W Director | Design Therapeutics, Inc. (DSGN) | 09-Dec-22 | Private Purchase | 15,000 | $7.96 | $119,426.00 | 15% 97.02K to 112.02K | |
| 22-Mar-22 7:26 PM View: | Xu Stella Director | Design Therapeutics, Inc. (DSGN) | 22-Mar-22 | Sale | 1,455 | $18.63 | $27,105.50 | (< 1%) 4.14M to 4.14M | |
| 22-Mar-22 7:28 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 21-Mar-22 | Market Purchase | 25,000 | $18.99 | $474,680.00 | < 1% 6.02M to 6.05M | (7%) |
| 22-Mar-22 7:26 PM View: | Xu Stella Director | Design Therapeutics, Inc. (DSGN) | 21-Mar-22 | Sale | 24,000 | $19.01 | $456,240.00 | (< 1%) 4.17M to 4.14M | |
| 22-Mar-22 7:26 PM View: | Xu Stella Director | Design Therapeutics, Inc. (DSGN) | 18-Mar-22 | Private Sale | 565,425 | $19.07 | $10,782,900.00 | (12%) 4.73M to 4.17M | |
| 18-Mar-22 5:37 PM View: | Prasad Deepa Director | Design Therapeutics, Inc. (DSGN) | 16-Mar-22 | Acquisition (other) | 11,806 | -- | -- | 100% 0 to 11.81K | |
| 02-Sep-21 5:06 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 31-Aug-21 | Market Purchase | 40,000 | $15.45 | $618,000.00 | < 1% 5.98M to 6.02M | 3% |
| 01-Apr-21 6:16 PM View: | Shah Pratik Executive Chairperson Director | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 25,000 | $20.00 | $500,000.00 | 19% 129.92K to 154.92K | |
| 01-Apr-21 6:14 PM View: | Thacker Justin Vice President, Finance | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 17,500 | $20.00 | $350,000.00 | 100% 0 to 17.5K | |
| 01-Apr-21 6:19 PM View: | Xu Stella Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 10,000 | $20.00 | $200,000.00 | < 1% 9.44M to 9.45M | |
| 01-Apr-21 4:15 PM View: | Cormorant Asset Management,... | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 4,364,840 | -- | -- | 100% 4.36M to 8.73M | |
| 01-Apr-21 6:18 PM View: | George Simeon Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion Duplicate | 5,376,480 | -- | -- | 100% 0 to 5.38M | |
| 01-Apr-21 6:12 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 2,032,500 | -- | -- | 63% 3.25M to 5.28M | |
| 01-Apr-21 6:23 PM View: | Sr One Capital Fund I Aggre... 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 5,376,480 | -- | -- | 100% 0 to 5.38M | |
| 01-Apr-21 4:15 PM View: | Cormorant Asset Management,... | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 750,000 | $20.00 | $15,000,000.00 | 9% 8.73M to 9.48M | |
| 01-Apr-21 6:18 PM View: | George Simeon Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase Duplicate | 250,000 | $20.00 | $5,000,000.00 | 5% 5.38M to 5.63M | |
| 01-Apr-21 6:16 PM View: | Shah Pratik Executive Chairperson Director | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 104,923 | -- | -- | 420% 25.0K to 129.92K | |
| 01-Apr-21 6:12 PM View: | William Arsani Director | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 700,000 | $20.00 | $14,000,000.00 | 13% 5.28M to 5.98M | |
| 01-Apr-21 6:19 PM View: | Xu Stella Director 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion Duplicate | 4,720,830 | -- | -- | 100% 4.72M to 9.44M | |
| 01-Apr-21 6:23 PM View: | Sr One Capital Fund I Aggre... 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 250,000 | $20.00 | $5,000,000.00 | 5% 5.38M to 5.63M | |
| 01-Apr-21 6:35 PM View: | Jeffries Sean Chief Operating Officer | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 3,050 | $20.00 | $61,000.00 | 100% 0 to 3.05K | |
| 01-Apr-21 6:25 PM View: | Quan Venture Fund Ii, L.P. 10% Owner | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 4,720,830 | -- | -- | 100% 0 to 4.72M | |
| 01-Apr-21 6:17 PM View: | Lappe Rodney W Director | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 5,000 | $20.00 | $100,000.00 | 5% 92.02K to 97.02K |
